SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $523 | -16.2% | 11,120 | -25.2% | 0.07% | +13.8% |
| Q1 2023 | $624 | -99.9% | 14,876 | -10.8% | 0.06% | -4.9% |
| Q2 2022 | $539,000 | +54.4% | 16,680 | +258.1% | 0.06% | +56.4% |
| Q1 2021 | $349,000 | +4.5% | 4,658 | -60.0% | 0.04% | -40.0% |
| Q1 2020 | $334,000 | +7.1% | 11,646 | +424.1% | 0.06% | +18.2% |
| Q3 2019 | $312,000 | +10.2% | 2,222 | +43.5% | 0.06% | +14.6% |
| Q2 2019 | $283,000 | -76.7% | 1,548 | -82.0% | 0.05% | -71.4% |
| Q3 2018 | $1,213,000 | +70.8% | 8,587 | +99.4% | 0.17% | +33.3% |
| Q4 2017 | $710,000 | +18.7% | 4,306 | -42.7% | 0.13% | +11.5% |
| Q2 2017 | $598,000 | +196.0% | 7,513 | +164.4% | 0.11% | +140.4% |
| Q1 2017 | $202,000 | – | 2,842 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |